User profiles for Elisha M. Wachman

Elisha M. Wachman, MD

Associate Professor of Pediatrics, Boston University School of Medicine
Verified email at bmc.org
Cited by 3048

The effects of noise on preterm infants in the NICU

EM Wachman, A Lahav - Archives of Disease in Childhood-Fetal and …, 2011 - fn.bmj.com
Preterm infants in the neonatal intensive care unit (NICU) are constantly exposed to ambient
noise that often exceeds recommended levels. There is a growing concern that such noise …

Association of OPRM1 and COMT single-nucleotide polymorphisms with hospital length of stay and treatment of neonatal abstinence syndrome

EM Wachman, MJ Hayes, MS Brown, J Paul… - Jama, 2013 - jamanetwork.com
Importance Neonatal abstinence syndrome (NAS) caused by in utero opioid exposure is a
growing problem; genetic factors influencing the incidence and severity have not been …

Consistent localization of SARS-CoV-2 spike glycoprotein and ACE2 over TMPRSS2 predominance in placental villi of 15 COVID-19 positive maternal-fetal dyads

…, E Barnett, V Sabharwal, C Yarrington, EM Wachman - Placenta, 2020 - Elsevier
Introduction While the COVID-19 pandemic continues to have a significant global health
impact, rates of maternal to infant vertical transmission remain low (<5%). Parenchymal …

Neonatal abstinence syndrome: advances in diagnosis and treatment

EM Wachman, DM Schiff, M Silverstein - Jama, 2018 - jamanetwork.com
Importance Neonatal abstinence syndrome, which occurs as a result of in utero opioid
exposure, affects between 6.0 and 20 newborns per 1000 live US births. There is substantial …

[HTML][HTML] Review of the assessment and management of neonatal abstinence syndrome

SM Bagley, EM Wachman, E Holland… - Addiction science & …, 2014 - Springer
Neonatal abstinence syndrome (NAS) secondary to in-utero opioid exposure is an increasing
problem. Variability in assessment and treatment of NAS has been attributed to the lack of …

[HTML][HTML] Caring for pregnant women with opioid use disorder in the USA: expanding and improving treatment

…, EM Wachman, P Mehta, A Vilkins, M Sia… - Current obstetrics and …, 2016 - Springer
Purpose of the Review Opioid use disorder in the USA is rising at an alarming rate, particularly
among women of childbearing age. Pregnant women with opioid use disorder face …

Quality improvement initiative to improve inpatient outcomes for neonatal abstinence syndrome

EM Wachman, M Grossman, DM Schiff… - Journal of …, 2018 - nature.com
Objectives To improve Neonatal Abstinence Syndrome (NAS) inpatient outcomes through a
comprehensive quality improvement (QI) program. Design Inclusion criteria were opioid-…

Impact of parental presence at infants' bedside on neonatal abstinence syndrome

…, T Wolfgang, JM Moses, EM Wachman - Hospital …, 2017 - publications.aap.org
BACKGROUND: Despite increased incidence of neonatal abstinence syndrome (NAS) over
the past decade, minimal data exist on benefits of parental presence at the bedside on NAS …

Epigenetic variation in the mu-opioid receptor gene in infants with neonatal abstinence syndrome

EM Wachman, MJ Hayes, BM Lester, N Terrin… - The Journal of …, 2014 - Elsevier
… Author links open overlay panel Elisha M. Wachman MD 1 , Marie J. Hayes PhD 2 , Barry …
The bisulfite-treated DNA was eluted in 20 μL of M-Elution Buffer. The Human Methylated & …

Breastfeeding rates among mothers of infants with neonatal abstinence syndrome

EM Wachman, J Byun, BL Philipp - Breastfeeding Medicine, 2010 - liebertpub.com
Background: Woman who struggle with drug addiction during pregnancy are perhaps the
most vulnerable of new mothers. The opioid substitution medications methadone and …